AMNIOXPRESS Trademark

Trademark Overview


On Monday, April 22, 2024, a trademark application was filed for AMNIOXPRESS with the United States Patent and Trademark Office. The USPTO has given the AMNIOXPRESS trademark a serial number of 98512922. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, June 24, 2025. This trademark is owned by MiMedx Group, Inc.. The AMNIOXPRESS trademark is filed in the Pharmaceutical Products category with the following description:

Human biological amniotic membrane tissue intended for subsequent implantation; topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; wound treatment in the nature of a dressing comprising amniotic material; allograft made from amniotic material
amnioxpress

General Information


Serial Number98512922
Word MarkAMNIOXPRESS
Filing DateMonday, April 22, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, June 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2024

Trademark Statements


Goods and ServicesHuman biological amniotic membrane tissue intended for subsequent implantation; topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; wound treatment in the nature of a dressing comprising amniotic material; allograft made from amniotic material

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMiMedx Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarietta, GA 30062

Party NameMiMedx Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarietta, GA 30062

Trademark Events


Event DateEvent Description
Monday, April 22, 2024NEW APPLICATION ENTERED
Monday, April 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 9, 2024ASSIGNED TO EXAMINER
Wednesday, November 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 24, 2025SOU EXTENSION 1 FILED
Tuesday, June 24, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, June 24, 2025SOU EXTENSION 1 GRANTED
Wednesday, June 25, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED